✦ LIBER ✦

Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China

✍ Scribed by Yi-Long WU; Da-Tong CHU; Baohui HAN; Xuyi LIU; Li ZHANG; Caicum ZHOU; Meilin LIAO; Tony MOK; Haiyi JIANG; Emma DUFFIELD; Masahiro FUKUOKA

Book ID: 114829937
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 815 KB
Volume: 8
Category: Article
ISSN: 1743-7555
DOI: 10.1111/j.1743-7563.2012.01518.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarker Analyses and Final Overall Sur

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)

✍ Fukuoka, M.; Wu, Y.-L.; Thongprasert, S.; Sunpaweravong, P.; Leong, S.-S.; Sriur 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 241 KB

Vinorelbine plus gemcitabine followed by

Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study

✍ Kaoru Kubota; Masaaki Kawahara; Mitsumasa Ogawara; Yutaka Nishiwaki; Kiyoshi Kom 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 173 KB

Randomized phase II study of first-line

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

✍ Niho, Seiji; Kunitoh, Hideo; Nokihara, Hiroshi; Horai, Takeshi; Ichinose, Yukito 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 408 KB

PP47 First line gefitinib versus first l

PP47 First line gefitinib versus first line chemotherapy by carboplatin plus paclitaxel in non-small cell lung cancer patients with EGFR mutations: a phase III study (002) by North East Japan Gefitinib Study Group

✍ Y. Minegishi; A. Inoue; K. Kobayashi; A. Gemma; M. Maemondo; S. Oizumi; Y. Saijo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Weekly nab-Paclitaxel in Combination Wit

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial

✍ Socinski, M. A.; Bondarenko, I.; Karaseva, N. A.; Makhson, A. M.; Vynnychenko, I 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 207 KB

A phase II study of carboplatin and pacl

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB